Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of an arsenic compound and at least one retinoid for treating acute myeloid leukemia

Combination of an arsenic compound and at least one retinoid for treating acute myeloid leukemia

US Patent 11077139 · Granted Aug 3, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dactinomycin compositions and methods for the treatment of acute myeloid leukemi2022
Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses there2019
Dactinomycin compositions and methods for the treatment of acute myeloid leukemi2019
Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses there2018
Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses there2017
Drug monitoring methods using the promyelocytic leukemia protein as a redox sens2016
Method for monitoring minimal residual hairy cell leukemia2015
Methods, pharmaceutical compositions and kits for use in the treatment of adult 2015
Methods, pharmaceutical compositions and kits for use in the treatment of adult 2015
Methods, pharmaceutical compositions and kits for use in the treatment of adult 2014
Methods, pharmaceutical compositions and kits for use in the treatment of adult 2014
Promyelocytic leukemia protein as a redox sensor2014